Literature DB >> 23579878

Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).

Markus Peck-Radosavljevic1, Bernhard Angermayr, Christian Datz, Arnulf Ferlitsch, Monika Ferlitsch, Valentin Fuhrmann, Michael Häfner, Ludwig Kramer, Andreas Maieron, Berit Payer, Thomas Reiberger, Rudolf Stauber, Rudolf Steininger, Michael Trauner, Siegfried Thurnher, Gregor Ulbrich, Wolfgang Vogel, Heinz Zoller, Ivo Graziadei.   

Abstract

In November 2004, the Austrian Society of Gastroenterology and Hepatology (ÖGGH) held for the first time a consensus meeting on the definitions and treatment of portal hypertension and its complications in the Billroth-Haus in Vienna, Austria (Billroth I-Meeting). This meeting was preceded by a meeting of international experts on portal hypertension with some of the proponents of the Baveno consensus conferences (http://www.oeggh.at/videos.asp). The consensus itself is based on the Baveno III consensus with regard to portal hypertensive bleeding and the suggestions of the International Ascites Club regarding the treatment of ascites. Those statements were modified by new knowledge derived from the recent literature and also by the current practice of medicine as agreed upon by the participants of the consensus meeting. In October 2011, the ÖGGH organized the second consensus meeting on portal hypertension and its complications in Vienna (Billroth II-Meeting). The Billroth II-Guidelines on the definitions and treatment of portal hypertension and its complications take into account the developments of the last 7 years, including the Baveno-V update and several key publications.

Entities:  

Mesh:

Year:  2013        PMID: 23579878     DOI: 10.1007/s00508-013-0337-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  120 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

Authors: 
Journal:  J Hepatol       Date:  2011-03-01       Impact factor: 25.083

3.  Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience.

Authors:  Tomohiko Akahoshi; Makoto Hashizume; Rinshyun Shimabukuro; Kazuo Tanoue; Morimasa Tomikawa; Keishi Okita; Norikazu Gotoh; Kouzou Konishi; Norifumi Tsutsumi; Keizo Sugimachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

4.  Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.

Authors:  Masafumi Kumamoto; Atsushi Toyonaga; Hiroto Inoue; Kenji Miyakoda; Yukihiko Morita; Keigo Emori; Yoshihiro Sakamoto; Kazuhiko Oho; Michio Sata
Journal:  J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 4.029

5.  TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.

Authors:  Martin Rössle; Alexander L Gerbes
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

6.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

8.  Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience.

Authors:  Rupesh Rajani; Tor Melin; Einar Björnsson; Ulrika Broomé; Per Sangfelt; Ake Danielsson; Anders Gustavsson; Olof Grip; Hans Svensson; Lars Lööf; Sven Wallerstedt; Sven H C Almer
Journal:  Liver Int       Date:  2008-08-07       Impact factor: 5.828

9.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.

Authors:  Christophe Bureau; Jean-Marie Péron; Laurent Alric; Joséphine Morales; Jérôme Sanchez; Karl Barange; Jean-Louis Payen; Jean-Pierre Vinel
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

View more
  17 in total

1.  Therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.

Authors:  Hongwei Lu; Sida Liu; Yafei Zhang; Hao Shang; Hong Ji; Yiming Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  [Pulmonary complications in liver diseases].

Authors:  T Horvatits; A Drolz; K Rutter; S Kluge; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-26       Impact factor: 0.840

Review 3.  [Hepatocardiac disorders : Interactions between two organ systems].

Authors:  T Horvatits; A Drolz; K Rutter; K Roedl; S Kluge; V Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-06-13       Impact factor: 0.840

Review 4.  Utility of endoscopic ultrasound in patients with portal hypertension.

Authors:  Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

5.  Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.

Authors:  Benedikt Simbrunner; Annika Röthenbacher; Helmuth Haslacher; David Bauer; David Chromy; Theresa Bucsics; Philipp Schwabl; Rafael Paternostro; Bernhard Scheiner; Michael Trauner; Mattias Mandorfer; Ilse Schwarzinger; Thomas Reiberger
Journal:  United European Gastroenterol J       Date:  2019-04-05       Impact factor: 4.623

6.  Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.

Authors:  Theresa Bucsics; Katharina Lampichler; Constantin Vierziger; Maria Schoder; Florian Wolf; David Bauer; Benedikt Simbrunner; Lukas Hartl; Mathias Jachs; Bernhard Scheiner; Michael Trauner; Thomas Gruenberger; Franz Karnel; Mattias Mandorfer; Thomas Reiberger
Journal:  Dig Dis Sci       Date:  2022-03-17       Impact factor: 3.199

7.  Study of the association between hemorrhage and the position of hemorrhagic stigmata in patients with esophageal varices.

Authors:  Shao-Hua Shen; Ying-Di Liu; Xiao Sun; Meng Li; Guo-Hui Sun; Juan Wang; Jiang-Tao Liu; Jun Tie; Jing Yang
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

8.  Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.

Authors:  Mattias Mandorfer; Simona Bota; Philipp Schwabl; Theresa Bucsics; Nikolaus Pfisterer; Christian Summereder; Michael Hagmann; Alexander Blacky; Arnulf Ferlitsch; Wolfgang Sieghart; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

9.  The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.

Authors:  Stephanie Hametner; Arnulf Ferlitsch; Monika Ferlitsch; Alexandra Etschmaier; Rainer Schöfl; Alexander Ziachehabi; Andreas Maieron
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

10.  The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.

Authors:  Bernhard Scheiner; Mattias Mandorfer; Philipp Schwabl; Berit Anna Payer; Theresa Bucsics; Simona Bota; Maximilian C Aichelburg; Katharina Grabmeier-Pfistershammer; Albert Stättermayer; Peter Ferenci; Michael Trauner; Markus Peck-Radosavljevic; Thomas Reiberger
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.